Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity
- 19 February 2008
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (4) , 447-456
- https://doi.org/10.1097/qad.0b013e3282f42412
Abstract
To evaluate the recognition of computationally designed, centralized HIV-1 antigens derived from clade B, C and group M sequences by individuals infected with HIV-1-M clades B and C. Three centralized sequences have been described - consensus, ancestor and center-of-tree - each of which attempts to minimize the genetic distance to circulating viruses. It is unclear whether any of these sequences affords an advantage for T cell recognition. The ability of centralized clade B and C and group M peptides to be targeted in ELISpot assays was assessed using samples from the United States, Peru, Barbados and South Africa. Each of the clade-specific centralized peptide sets was equally powerful in detecting cytotoxic T cell (CTL) responses. Importantly, combination of these sets detected significantly broader responses. Although broad responses were observed in populations from which few sequences informed the design of these centralized sequences, the genetic distance between local sequences and the respective test set was inversely associated with response rates. Furthermore, the CTL reactivity in clade C-infected subjects using clade B peptides was reduced relative to within-clade peptide responses, while responses to group M peptides were comparable to within-clade peptide responses in these individuals. All tested centralized antigens provided a similarly potent set of antigenic peptides. However, the significantly broader responses detected using the combination of sets highlight the importance of maximizing coverage of HIV-1 sequence diversity in vaccine preparations, as well as in the evaluation of CTL responses in HIV-1-infected individuals and those vaccinated.Keywords
This publication has 31 references indexed in Scilit:
- Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 ProteinsJournal of Virology, 2007
- Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteinsVirology, 2006
- Ancestral and consensus envelope immunogens for HIV-1 subtype CVirology, 2006
- A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary virusesVirology, 2006
- Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B EnvelopeJournal of Virology, 2005
- Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope GlycoproteinJournal of Virology, 2005
- Centralized immunogens as a vaccine strategy to overcome HIV-1 diversityExpert Review of Vaccines, 2004
- Prospects for an AIDS vaccine: three big questions, no easy answersThe Lancet Infectious Diseases, 2004
- Consensus and Ancestral State HIV VaccinesScience, 2003
- Diversity Considerations in HIV-1 Vaccine SelectionScience, 2002